Development, verification, and comparison of a risk stratification model integrating residual cancer burden to predict individual prognosis in early-stage breast cancer treated with neoadjuvant therapy.
Hou N, Wu J, Xiao J, Wang Z, Song Z, Ke Z, Wang R, Wei M, Xu M, Wei J, Qian X, Xu X, Yi J, Wang T, Zhang J, Li N, Fan J, Hou G, Wang Y, Wang Z, Ling R.
Hou N, et al. Among authors: wei m, wei j.
ESMO Open. 2021 Oct;6(5):100269. doi: 10.1016/j.esmoop.2021.100269. Epub 2021 Sep 16.
ESMO Open. 2021.
PMID: 34537675
Free PMC article.
Clinical Trial.